VALIDATE's Impacts & Achievements
VALIDATE aims to accelerate vaccine R&D for our focus pathogens and further our members' careers, as well as providing other research and capacity building opportunities. Since starting in 2017, VALIDATE activities have supported:
- the formation of 240 new collaborations
- 102 publications
- Our events have attracted >3,900 attendees from 80 countries
- VALIDATE activities have stimulated >£26M in follow-on funding
Find out more about our activities and achievements via the tiles below.
